Semenya Condemns Olympic Sex Verification Tests as 'Disrespect for Women'

South African athletics legend Caster Semenya has strongly condemned the International Olympic Committee's decision to reinstate sex verification testing for the 2028 Los Angeles Olympics, characterizing the policy as fundamentally disrespectful toward women athletes.

The two-time Olympic 800m champion voiced her criticism during a Cape Town press conference, expressing particular disappointment that the controversial measure was implemented under IOC President Kirsty Coventry of Zimbabwe.

"For me, personally, for her being a woman coming from Africa, knowing how African women or women in the global south are affected by that, of course, it causes harm," Semenya stated, highlighting the disproportionate impact on athletes from developing regions.

The IOC announced Thursday that genetic testing will return to Olympic competition for the first time since 1999, requiring athletes to undergo SRY gene screening through saliva, cheek swab, or blood samples. This policy effectively excludes transgender athletes and many intersex competitors from women's events.

Semenya, who possesses male XY chromosomes due to a differences in sex development (DSD) condition, has become the symbolic figure in this ongoing battle. Her career has been marked by legal challenges and regulatory disputes since winning her first world championship in 2009.

"It came as a failure. And that's why it was dropped," Semenya said, referencing the IOC's previous abandonment of chromosomal testing in 1999 following scientific criticism and athlete opposition.

The current policy reversal comes after significant controversy surrounding the women's boxing competition at the 2024 Paris Olympics. Algerian fighter Imane Khelif and Lin Yu-ting of Chinese Taipei became central figures in heated debates about athlete eligibility, despite both winning gold medals.

Khelif and Lin had been excluded from the International Boxing Association's 2023 world championships after failing eligibility tests, but the IOC permitted their Paris participation, describing their previous exclusion as "sudden and arbitrary."

The new testing protocol represents a dramatic shift from recent Olympic policy, which had moved away from genetic verification toward more nuanced approaches considering individual circumstances. The decision aligns with broader political pressures, particularly from the Trump administration, which issued executive orders banning transgender athletes from women's sports.

Semenya's critique extends beyond personal grievance to broader philosophical concerns about women's athletic participation. "It's like now we need to prove that we are worthy as women to take part in sports. That's a disrespect for women," she emphasized.

The policy impacts extends beyond transgender athletes to include those with DSD conditions, rare genetic variations affecting hormone production, chromosomal patterns, and reproductive development. These athletes often face complex medical and legal challenges while pursuing elite competition.

Various sports have adopted differing approaches to athlete eligibility. Swimming, athletics, cycling, and rowing have implemented comprehensive bans, while other disciplines have permitted competition following testosterone suppression treatments.

The Los Angeles Olympics will serve as the first major international competition implementing the renewed testing protocols. The policy's effectiveness and fairness will likely face scrutiny from athletes, scientific communities, and human rights organizations.

Semenya's activism continues influencing global conversations about inclusion, fairness, and human dignity in sport. Her persistent advocacy challenges traditional categorizations while defending the rights of athletes whose biology doesn't conform to conventional expectations.

As the 2028 Olympics approach, the debate surrounding athlete eligibility remains far from resolved, with Semenya's voice representing those seeking competitive opportunities while maintaining their authentic identities.